Reports on Helicobacter pylori infection in diabetics are inconsistent and contradictory. This study attempted to identify the possible association between type 2 diabetes and H. pylori infection.
Introduction
A s a microaerophilic bacterium (Gram-negative), Helicobacter is known to cause infection in gastric mucous layer's epithelial lining. As a matter of the fact, it is the primary reason for chronic gastritis, and those infected with this bacterium are faced with a significantly heightened risk of being diagnosed with gastric cancer. It is also responsible for nearly 90% of all peptic ulcer cases. A systematic worldwide study conducted in 2015 showed that nearly 4.4 billion individuals were reported to be positive for Helicobacter pylori, which is more common in low socioeconomic populations, Hispanics, Asian Americans, as well as older adults. [1] For this reason, the prevalence of H. pylori is greater in developing countries. [2] This high prevalence has also been observed in Saudi Arabia although studies conducted recently suggest that the prevalence of infection has dropped considerably.
Infection with H. pylori is commonly associated with several gastric diseases (e.g. chronic gastritis, peptic ulceration, and gastric cancer), [3] as well as extra-gastrointestinal disorders such as metabolic syndrome and cardiovascular diseases, and some have been characterized by persistent and low-grade systemic inflammation. [4] Although H. pylori infection and diabetes mellitus are two separate diseases, it has been observed that poor glycemic control in type 2 diabetics is related to higher rates of H. pylori infection. H. pylori infection has been described as one of the most common complications in diabetics with gastric symptoms. [5] Chung et al. [6] observed that the eradication of H. pylori improves insulin resistance. Talley et al. [7] added that neuropathy and hyperglycemia play an important role in H. pylori colonization in the gastric epithelium. Furthermore, a significant correlation has been observed between H. pylori infection and microvascular complications. [8] Reports on H. pylori infection in diabetic patients have been found to be conflicting and inconsistent, [9] the prevalence of H. pylori in type 2 diabetic patients having been reported as high, [10, 11] low, [12] or even normal. [13] Therefore, the association of diabetes mellitus and infection with H. pylori has to be explored.
The aim of the present study was to identify the possible association between type 2 diabetes and H. pylori infection.
Materials and Methods
This study using a cross-sectional design was conducted from December 2017 to November 2018. Participants were recruited from four Primary Health Care of National Guard (NG) Centers in Jeddah City, Saudi Arabia (Alwaha, Iskan, Family Medicine Clinic NG Hospital, and Bahra Centers).
The sample size was determined according to the association of H. pylori with type 2 diabetes, assuming a 13% frequency difference between diabetic and nondiabetic patients provided in the published reports. [14, 15] Under these parameters, we estimated that approximately 210 diabetic patients and 210 nondiabetic patients (control subjects) would provide 80% of the power to reject the null hypothesis at P < 0.05. We included individuals aged 40 years and above. Exclusion criteria were patients known to have H. pylori and who have received eradication treatment or were on proton pump inhibitor, those with hemoglobinopathies and with a previous history of renal failure, chronic liver disease, or malignant disease, or those on immunosuppressant agents.
The diabetics (cases) were selected randomly from the chronic disease clinic of the primary health care centers, and the nondiabetics were randomly selected from the day-to-day appointment list of those who presented at the primary health care centers with ailments other than diabetes mellitus. The study utilized a questionnaire to gather information on their sociodemographic characteristics. All participants underwent hemoglobin A1c (HbA1c) assessment and stool antigen test for H. pylori.
The control subjects were proven as nondiabetics by HbA1c performed according to the American Diabetes Association's Criteria of Medical Care in Diabetes. [16] The 13C-urea breath test is accepted as a reliable noninvasive test for detecting H. pylori infection, but this 13C-urea breath test was not available in most clinical care centers, particularly in primary health care centers. The stool antigen test of H. pylori, the validity of which, has been well studied and approved as an alternative test for the 13C-urea breath test was, however, available in the primary care centers. Tanaka and Takahashi [17] found that the specificity and sensitivity of the H. pylori stool antigen test were 95% and 98.3%, respectively, for primary diagnosis.
Ethical approval from the institutional review board/ ethics committee was obtained, and informed written consent was taken from all participants. The researchers obtained an official approval from the directors of the primary health care centers for the study. Symptomatic participants who were positive for the stool antigen test were given the necessary treatment.
IBM SPSS Statistics program software version 24 (2015)
was used to analyze the data. Frequency and percentages were calculated. The data were expressed by mean ± standard deviation of age among the numerical parameters. The t-test was used to compare the means of two independent groups. The Chi-square test was applied to compare categorical variables, with two or more categories (e.g., H. pylori positive and negative with gender and other categorical risk factors). Multivariate regression analysis was performed to identify the risk factors associated with the presence of H. pylori infection. Odds ratios and their 95% confidence intervals were calculated. P < 0.05 was considered statistically significant.
Results
A total of 212 diabetic patients aged 40 years or more and 209 age-matched nondiabetic subjects were included. Figure 1 shows that 26.9% of the diabetics and 26.3% of the nondiabetics were positive with H. pylori. There was no significant difference between the two groups of participants regarding the prevalence of H. pylori. Table 1 shows that, of the type 2 diabetics, the prevalence of H. pylori did not differ significantly according to their age groups, gender, smoking status, body mass index, or chronic diseases. Moreover, it shows that, of the nondiabetics, the prevalence of H. pylori was significantly higher in overweight and obese subjects (P = 0.013). However, it did not differ significantly with regard to their age groups, gender, smoking status, chronic diseases, or their health care center. Table 2 shows that the prevalence of H. pylori in the diabetics did not differ significantly by their HbA1c level, duration of diabetes, or type of therapy received. Table 3 shows the results of multivariate regression analysis of factors that predict diabetes mellitus in the studied population. Male patients and those with hypertension or dyslipidemia were significantly associated with diabetes mellitus (P < 0.05). Although older patients (≥60 years old), smokers, and those with positive H. pylori were more likely to have diabetes mellitus, none of the differences were statistically significant (P > 0.05).
Discussion
The results of this study revealed that the prevalence of H. pylori infection was slightly higher in diabetics than in nondiabetics (26.9% and 26.3%, respectively). This finding accords with those of several studies.
The prevalence of H. pylori infection in type 2 diabetics ranges from 30% to 78%. [9] Bener et al. [18] stated that the variability in prevalence of H. pylori infection might be attributed to epidemiological distribution of H. pylori.
Regarding risk factors of H. pylori infection, the current study showed that of the diabetics, there was no significant difference as regards their HbA1c level, duration of diabetes, or type of therapy received. Moreover, H. pylori infection was highest in obese participants of both groups. However, the prevalence of H. pylori infection did not differ significantly according to gender or smoking status.
Chen and Blaser [19] described a synergistic effect of body mass index and H. pylori infection on increased levels of HbA1c, indicating a possible role of H. pylori infection in adults with impaired glucose tolerance possibly potentiated by a higher body mass index.
Malecki et al. [12] reported no association between H. pylori infection, levels of HbA1c, and duration of diabetes with upper gastrointestinal symptoms in diabetics. Moreover, Oluyemi et al. [20] noted that the prevalence of H. pylori was neither associated with duration of diabetes nor associated with gender, body mass index, smoking status, or age.
The present study showed no significant difference in the prevalence of H. pylori infection between diabetics and nondiabetics. This finding is in accordance with those of other studies which reported no significant difference in the prevalence of H. pylori infection between diabetics and nondiabetics.
In Hong Kong, Malecki et al. [12] reported the prevalence of H. pylori infection in Chinese subjects with type 2 diabetes at around 50%, similar to that of the control subjects. In Athens, Greece, Anastasios et al. [9] stated that the H. pylori infection was slightly higher in diabetics than in nondiabetics (37.3% and 35.2%, respectively), but the difference was not statistically significant. [21] demonstrated a higher body mass index in patients with H. pylori infection. Bener et al. [18] noted that the prevalence of H. pylori infection was higher in obese type 2 diabetic patients as opposed to the normal population. Takashima et al. [22] added that H. pylori infection has been shown to interfere with serum lipid profile of patients and can, therefore, be a risk factor for diabetes. Salih [23] stated that, in adults, H. pylori infection increased with age, but no association was found between H. pylori infection and age in our study. Zaterka et al. [24] noted that smoking was considered as a risk factor for H. pylori infection. However, the association between H. pylori infection and smoking has been attributed mainly to the socioeconomic conditions of patients. [25] Other studies have also reported no association between H. pylori infection and diabetes. Xia et al., [26] in China, noted that seroprevalence of H. pylori infection was not significantly different in diabetics compared to nondiabetic controls. Oluyemi et al. [20] also found no significant difference in the prevalence of H. pylori infection between type 2 diabetics and controls in Nigeria. Similar findings have been reported in other countries, including Italy, [27] China, [28] Turkey, [29] and Romania. [30] He et al. [31] noted that the discrepancies concerning the reported association between H. pylori infection and diabetes might be the result of the differences in the methods used to define H. pylori positivity and diabetic status, limited sample sizes, and adjustments for potential confounders, such as age and socioeconomic status. Moreover, the sources of bias may include inaccuracies of self-reported data, which mainly depends on participants' knowledge and understanding of the relevant information, their ability to recall, and their willingness to report.
Cohen and Muhsen
It is to be noted that the lack of significant differences regarding H. pylori infection in diabetics in the present study regarding their HbA1c level, duration of diabetes, or type of therapy received supports the lack of association between H. pylori infection and type 2 diabetes mellitus. Therefore, the results of the present study indicate that diabetes mellitus might not be a risk factor for H. pylori infection and vice versa, in the population in Jeddah, Saudi Arabia. This is also in agreement with Tamura et al. [32] in Japan, who reported negative or neutral results for such an association.
Vafaeimanesh et al. [33] stated that, regardless of the debate about which causes the other, the association between diabetes and H. pylori needs to be reviewed in different studies.
On the other hand, some case-control studies h a v e r e p o r t e d t h a t H . p y l o r i i n f e c t i o n w a s significantly associated with diabetes. [5, 18] Bener et al. [18] explained that H. pylori gastric infection increased the secretion of pro-inflammatory cytokines, resulting in changes in the structure of insulin receptor, thus interfering with the interaction between its receptor and insulin. Nevertheless, Anastasios et al. [9] stressed that there is no satisfactory explanation for the differences in H. pylori infection between diabetics and nondiabetics.
Hsieh et al. [34] reported that long-term H. pylori infection was significantly associated with high levels of HbA1c, decreased insulin secretion, and a higher prevalence of type 2 diabetes mellitus. These results seem to support the validity of the proper screening of H. pylori infection together with regular monitoring of blood glucose and HbA1c levels for the early detection of glucose dysregulation and the prevention of type 2 diabetes mellitus.
Moreover, Tamura et al., [32] who also found a significantly higher prevalence of diabetes in relation to H. pylori infection, reported that after age adjustment, there was no significant difference. They stated that the significant difference could be explained by the older age of those infected and the higher prevalence of diabetes in the elderly.
In addition, Azuma [35] stated that there are two major subtypes of CagA strain of H. pylori, i.e., the East Asian and the Western types. Only one-half to two-thirds of Western infections carry Western CagA, while nearly all East Asian strains have East Asian CagA. The association between H. pylori and diabetes has been hypothesized to be limited to Western CagA. [36, 37] Chen and Blaser [19] added that H. pylori seropositivity, but CagA positivity in particular, was associated with higher mean HbA1c levels. This association persisted even after excluding individuals with a history of diabetes and controlling for potential confounders.
The limitations of our current study are that we had limited data on systemic complications of diabetes mellitus in our study and we did not stress the complications of diabetes mellitus.
As part of this study, we did the stool antigen test (H. pylori), but the 13C-urea breath test and/or endoscopy were not done because of the limited access to these tests in the primary health care centers.
Further studies should be undertaken to evaluate the association between the complications of diabetes and H. pylori infection in relation to gastrointestinal disease in diabetics.
Conclusion
About one-quarter of type 2 diabetics and nondiabetics in Jeddah City had H. pylori infection. The lack of a significant difference between type 2 diabetic patients and controls regarding H. pylori infection suggests that there is no association between diabetes and H. pylori infection, although H. pylori infection is significantly higher patients with a high body mass index.
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